Physician profile
Amber Denham
NPI 1881802007
$1,684.51
in general payments reported to CMS, 2019-2025
21 companies · $235 in 2025
The $235 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $130 · 2021: $409 · 2022: $181 · 2023: $271 · 2024: $314 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $299.40 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $221.88 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $195.15 | 2019-2023 | Rotarix, Bexsero, Pediarix |
| Supernus Pharmaceuticals, INC. | $163.66 | 2021-2024 | Qelbree |
| Merck Sharp & Dohme LLC | $136.62 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $100.38 | 2021-2025 | |
| Sobi, INC | $98.52 | 2019-2023 | |
| Pfizer INC. | $74.72 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $60.29 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $50.73 | 2025 | |
| Corium, LLC | $49.34 | 2022-2023 | Azstarys |
| Biomarin Pharmaceutical INC. | $42.13 | 2024 | Voxzogo 1.2mg |
| Phadia US INC. | $37.83 | 2022-2025 | Immunocap |
| Cipher Pharmaceuticals US LLC | $30.39 | 2025 | Natroba, Spinosad |
| Biogen, INC. | $23.56 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $18.39 | 2023 | Flucelvax Quadrivalent |
| Ultragenyx Pharmaceutical INC. | $17.76 | 2024 | Crysvita |
| Neos Therapeutics, LP | $16.86 | 2022 | |
| Tris Pharma INC | $16.55 | 2025 | Dyanavel Xr |
| Cranial Technologies, INC | $15.50 | 2025 | Doc Band |
| Shire North American Group INC | $14.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Denham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.